Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Taipei Veterans General Hospital, Taiwan | OTHER_GOV |
| National Taiwan University Hospital | OTHER |
| Tri-Service General Hospital (TSGH) | OTHER |
| Chang Gung Memorial Hospital |
Not provided
Not provided
Not provided
Not provided
This project is a nationwide precision medicine program for urothelial carcinoma and renal cell carcinoma.
This project providing free and immediate next-generation gene sequencing testing for patients with urothelial and renal cell carcinomas that have is diagnosed or that have previously received systemic therapy. The goal of this project is to assist participating institutions in integrating next-generation sequencing results and building a real-time data storage and sharing platform, as well as establishing a tumor molecular biological atlas of Taiwanese patients with urothelial carcinoma and renal cell carcinoma. The data will be linked with clinical prognosis to facilitate the rapid screening of patients for effective potential therapeutic drugs and clinical trials, which is anticipated to prolong the survival rate of patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| kidney cancer | RCC arms: Retrospective studies for ccRCC (N=100) and nccRCC (N=100). The studies aim to obtain clinical information to correlate with genetic characterization of RCCs of all types. | ||
| urothelial cancer | UC arm: This is a prospective study for UC originated from the translational epithelium in the urinary tract (N=300). The study aims to obtain cancer tissues that originated from bladder (N=100), ureter (N=100), and renal pelvis (N=100). |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Development of an integrated database of genetic background | Development of an integrated database of genetic background from populations, underlying status, clinical information, and therapeutic outcomes in carcinogen-related advanced urologic tumors. | From date of registration to 30 Sep 2029 |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
urothelial carcinoma and renal cell carcinoma
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tai-Lung Cha, MD | Tri-Service General Hospital (TSGH) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yu wei-lan | Taipei | 10048 | Taiwan |
The data will be linked with clinical prognosis to facilitate the rapid screening of patients for effective potential therapeutic drugs and clinical trials, which is anticipated to prolong the survival rate of patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014571 | Urologic Neoplasms |
| ID | Term |
|---|---|
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| OTHER |
| Taichung Veterans General Hospital | OTHER |
| Kaohsiung Veterans General Hospital. | OTHER |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | OTHER |
Not provided
Not provided
Not provided
more than 30% of tumor compartments tissue. RCC arms (N=200): ccRCC (N=100) and nccRCC (N=100) or UC urinary tract (N=300). The study aims to obtain cancer tissues that originated from bladder (N=100), ureter (N=100), and renal pelvis (N=100).
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D014570 | Urologic Diseases |